EDTA chelation therapy modestly reduces cardiovascular events Chelation therapy, an unproven alternative medicine in the treatment for heart disease, modestly reduced cardiovascular events for adults aged 50 and older who had suffered a prior heart attack, according to new National Institutes of Health-supported research. Results from the chelation arm of the Trial to Assess Chelation Therapy (TAC